Antiviral research

[1] Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.

[2] a critical balance: dntps and the maintenance of genome stability

[3] 5-aza-2′,2′-difluoro deoxycytidine (nuc013): a novel nucleoside dna methyl transferase inhibitor and ribonucleotide reductase inhibitor for the treatment of cancer

[4] Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

[5] Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.

[6] 5-aza-2′,2′-difluoro deoxycytidine (nuc013): a novel nucleoside dna methyl transferase inhibitor and ribonucleotide reductase inhibitor for the treatment of cancer

[7] the impact of dutpase on ribonucleotide reductase-induced genome instability in cancer cells